Short answer
Hims & Hers Health, Inc. (HIMS) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results announced for quarter ended September 30, 2026.
Hims & Hers Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 results announced for quarter ended September 30, 2026
- Full operating and financial details contained in Exhibit 99.1 press release
Item 8.01 · Other Events
- Hims & Hers identifies websites, SEC filings, calls, blogs and social media as potential channels for material disclosures
- Investors should monitor the company’s investor relations and news websites for timely updates
- CEO Andrew Dudum’s X account included among designated information channels
- Disclosure policy increases importance of monitoring nontraditional channels beyond SEC filings
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $890.4M, up 49% year-over-year, with subscribers up 13% to 2.788M
- Revenue per average subscriber $105, up 30%, indicating monetization outpaced subscriber growth
- Gross margin fell to 57% from 74%, while net loss reached $33.0M versus $15.8M income
- Adjusted EBITDA $82.4M, but operating cash flow fell to $65.4M and free cash flow to $26.0M
- Full-year revenue guidance tightened to $3.13B-$3.15B, while Adjusted EBITDA guidance fell to $257M-$277M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Hims & Hers Health, Inc. 8-K filings
Get the next HIMS 8-K as it lands
Follow HIMS for push alerts, or ask the research agent what this filing means.